Attendee search 

J Rich Capital Inc. is an investment banking boutique with offices in Shanghai and Silicon Valley. Established in 2008, we specialize in mergers and acquisitions, capital raising, and asset management services within biotech, pharmaceutical, and real estate industries. Our expansive capital management capabilities as well as our deep understanding of the China market differentiate us from our peers in the financial industry.

纳米抗体研发,肿瘤免疫治疗

薄荷天使基金

生物科技公司

国内一线投行

聚焦表观遗传学为核心的产品开发

The project focuses on the research and development of anti-tumor photosensitizing drugs for photodynamic therapy, creating a research and development technology platform for photosensitizing drugs, and conducting clinical development and transformation of anti-tumor photosensitizing drugs. The new anti-tumor photosensitizer drugs developed by our team exhibited excellent tumor enrichment and high efficacy of photodynamic therapy. They have great potential for clinical development and application.

As the first professional injection producer in China,Shanghai Haipu Pharmaceutical factory was founded in 1925 and renamed as Shanghai Xudong Haipu Pharmaceutical Co.,Ltd after jointed with Taiwan Tungyang International Co.,Ltd in 1993.The company has developed for more than 90 years so far, and has accumulated rich experience in production and brand awareness.

混合所有制企业。

We are the flagship subsidiary of China Resources Group, engaging in the research and development, manufacturing, distribution and retail of a broad range of pharmaceutical and healthcare products.In 2018, our total revenue is HK$ 189.7 billion.
Currently CR Pharma Group is one of the TOP 3 pharmacetucial group in China, and our core competences is capabilities are marketing&sales(3000+ Sales Reps for RX and 3000+ Sales Reps for OTC and healthcare products, local Regulatory Affairs(Dedicated RA team), and great manufacturing facilities(40+ manufacturing sites in China, including API and finished products of all dosage forms, 4 sites are approved by US FDA and EMEA).
As a listed company in HK, CR Pharma has estalished consodiated business reputation in healtcare industry and capital market. And currently, nearly all top 50 MNC pharmacetical companies are our business partner in China, and business scope includes JV, Licensing, Commercial Distribution.